Remimazolam besylate approved for use in the UK for procedural sedation
Approval of this ultra-short acting anaesthetic is based on data from a US-based Phase III clinical trial programme in procedural sedation, evaluating the anaesthetic in patients undergoing bronchoscopy or colonoscopy.
Source:
PharmaTimes